perindopril has been researched along with Asystole in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (75.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akkerhuis, KM; Bertrand, ME; Boersma, E; Brugts, JJ; Danser, AH; de Maat, M; Ferrari, R; Fox, KM; Oemrawsingh, RM; Redekop, WK; Remme, WJ; Rudez, G; Simoons, ML; Van Vark, LC | 1 |
| Bertrand, M; Boersma, E; Brugts, JJ; Ceconi, C; Chalmers, J; Danser, AH; de Maat, MP; Ferrari, R; Fox, K; Isaacs, A; MacMahon, S; Ninomiya, T; Remme, W; Simoons, ML; Uitterlinden, AG; van Duijn, CM; Witteman, JC | 1 |
| Fox, KM | 1 |
| Legrand, V; Scheen, AJ | 1 |
| Böhm, M | 1 |
| Bertrand, ME; Daly, CA; Ferrari, R; Fox, KM; Remme, WJ; Simoons, ML | 1 |
| Bertrand, ME; Ferrari, R; Fox, KM; Remme, WJ; Simoons, ML | 1 |
| Bertrand, ME; Deckers, JW; Ferrari, R; Fox, KM; Remme, WJ; Simoons, ML | 1 |
1 review(s) available for perindopril and Asystole
| Article | Year |
|---|---|
Insight into ACE inhibition in the prevention of cardiac events in stable coronary artery disease: the EUROPA trial.
Topics: Angiotensin-Converting Enzyme Inhibitors; Coronary Angiography; Coronary Artery Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Europe; Female; Heart Arrest; Heart Failure; Humans; Male; Myocardial Infarction; Perindopril; Prognosis; Randomized Controlled Trials as Topic; Risk Assessment; Severity of Illness Index; Survival Rate | 2007 |
5 trial(s) available for perindopril and Asystole
| Article | Year |
|---|---|
Individualized Angiotensin-Converting Enzyme (ACE)-Inhibitor Therapy in Stable Coronary Artery Disease Based on Clinical and Pharmacogenetic Determinants: The PERindopril GENEtic (PERGENE) Risk Model.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Coronary Artery Disease; Cost-Benefit Analysis; Decision Support Techniques; Double-Blind Method; Drug Costs; Female; Genotype; Heart Arrest; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Patient Selection; Perindopril; Pharmacogenetics; Phenotype; Polymorphism, Single Nucleotide; Precision Medicine; Proportional Hazards Models; Receptor, Angiotensin, Type 1; Receptor, Bradykinin B1; Resuscitation; Risk Assessment; Risk Factors; Treatment Outcome | 2016 |
Genetic determinants of treatment benefit of the angiotensin-converting enzyme-inhibitor perindopril in patients with stable coronary artery disease.
Topics: Angiotensin-Converting Enzyme Inhibitors; Coronary Artery Disease; Female; Gene Frequency; Genotype; Heart Arrest; Humans; Kallikrein-Kinin System; Male; Middle Aged; Myocardial Infarction; Perindopril; Pharmacogenetics; Polymorphism, Single Nucleotide; Receptor, Angiotensin, Type 1; Receptor, Bradykinin B1; Renin-Angiotensin System | 2010 |
Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study).
Topics: Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Diseases; Cause of Death; Coronary Disease; Double-Blind Method; Female; Follow-Up Studies; Heart Arrest; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Perindopril; Treatment Outcome | 2003 |
[Clinical study of the month. The EUROPA study: cardiovascular protection with perindopril in patients with stable coronary heart disease].
Topics: Angiotensin-Converting Enzyme Inhibitors; Coronary Artery Disease; Double-Blind Method; Female; Heart Arrest; Humans; Male; Middle Aged; Myocardial Infarction; Perindopril; Placebos; Risk Factors; Treatment Outcome | 2003 |
The effect of perindopril on cardiovascular morbidity and mortality in patients with diabetes in the EUROPA study: results from the PERSUADE substudy.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Coronary Artery Disease; Death, Sudden, Cardiac; Diabetic Angiopathies; Double-Blind Method; Female; Heart Arrest; Humans; Male; Middle Aged; Myocardial Infarction; Perindopril; Prospective Studies | 2005 |
2 other study(ies) available for perindopril and Asystole
| Article | Year |
|---|---|
[ACE-inhibitor effects on the stabilization of coronary heart disease. EUROPA study].
Topics: Adolescent; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Cause of Death; Coronary Disease; Female; Heart Arrest; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Perindopril; Randomized Controlled Trials as Topic; Treatment Outcome | 2004 |
Effects of perindopril on long-term clinical outcome of patients with coronary artery disease and preserved left ventricular function.
Topics: Angiotensin-Converting Enzyme Inhibitors; Coronary Artery Disease; Female; Heart Arrest; Humans; Male; Middle Aged; Myocardial Infarction; Outcome Assessment, Health Care; Perindopril; Randomized Controlled Trials as Topic; Retrospective Studies; Stroke Volume; Ventricular Function, Left | 2007 |